Mississippi Drug Testing Consortium Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 49,374 | 49,016 | 358 | 15.7 | — |
| 2012 | 53,604 | 53,143 | 461 | 14.6 | — |
| 2013 | 53,893 | 55,798 | −1,905 | 13.4 | — |
| 2014 | 55,718 | 56,380 | −662 | 13.2 | — |
| 2015 | 57,740 | 47,830 | 9,910 | 18.0 | — |
| 2016 | 65,131 | 53,385 | 11,746 | 18.8 | — |
| 2017 | 58,948 | 54,876 | 4,072 | 19.2 | — |
| 2018 | 59,911 | 55,252 | 4,659 | 20.0 | — |
| 2019 | 52,551 | 54,810 | −2,259 | 19.7 | — |
| 2020 | 55,174 | 58,747 | −3,573 | 17.7 | — |
| 2021 | 47,058 | 59,181 | −12,123 | 15.1 | — |
| 2022 | 57,331 | 65,942 | −8,611 | 12.0 | — |
| 2023 | 60,898 | 62,242 | −1,344 | 12.4 | — |
In its most recent public year (2023), this organization spent $1,344 more than it brought in. Its reserves stood at about 12.4 months of spending, down from 15.7 in 2011.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Mississippi Drug Testing Consortium Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works